Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Some plant-based treatments can help with benign prostatic hyperplasia symptoms, but more research is needed to confirm their safety and effectiveness.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Using finasteride or dutasteride does not increase the risk of male breast cancer.

Minoxidil in breast milk may harm nursing infants.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Finasteride use may increase the risk of male breast cancer.

Caesalpinia bonduc seed extracts may help treat enlarged prostate in rats.

Purple corn extract may help reduce prostate enlargement and inflammation.

Late diagnosis of congenital adrenal hyperplasia can greatly affect physical development, gender identity, and sexual health.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

Pueraria mirifica extract may help treat benign prostatic hyperplasia.

Gene variation affects prostate issues and hair loss.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

Multiphoton microscopy can effectively assess breast cancer treatment responses without labels.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

A new system helps better diagnose and treat female androgenization conditions like PCOS.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Medical treatments for benign prostatic hyperplasia mainly relieve symptoms, while surgery is more effective but not always suitable for elderly patients.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Some parents have a mild form of congenital adrenal hyperplasia without symptoms, and they usually don't need treatment.

Non-classic congenital adrenal hyperplasia is a common disorder causing symptoms like acne and infertility, and it's managed based on symptoms, not just test results. Treatment can improve fertility and reduce miscarriage risk.

A woman's male-like symptoms and high testosterone were due to ovarian hilus-cell hyperplasia, which improved after surgery.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Reproductive hormones play a crucial role in breast cancer development and treatment challenges.